ArticleBMC health services research2022

Utilization and costs of epidermal growth factor receptor mutation testing and targeted therapy in Medicare patients with metastatic lung adenocarcinoma.

Chan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.